We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
424 result(s) found, displaying 271 to 280
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for AIRZATE ACCUHALER 500/50 fluticasone propionate 500 microgram/salmeterol (as xinafoate) 50 microgram powder for inhalation blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PAVTIDE ACCUHALER 500/50 fluticasone propionate 500 microgram/salmeterol (as xinafoate) 50 microgram powder for inhalation blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for AIRZATE ACCUHALER 250/50 fluticasone propionate 250 microgram/salmeterol (as xinafoate) 50 microgram powder for inhalation blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for BREO ELLIPTA fluticasone furoate 100 microgram / vilanterol (as trifenatate) 25 microgram powder for inhalation.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for BREO ELLIPTA fluticasone furoate 200 microgram / vilanterol (as trifenatate) 25 microgram powder for inhalation.
-
Australian public assessment report (AusPar)Australian Public Assessment Report for mepolizumab (rch)
-
Cancellation by sponsorRequested by GlaxoSmithKline Australia Pty Ltd
-
Cancellation by sponsorRequested by GlaxoSmithKline Australia Pty Ltd
-
Cancellation by sponsorRequested by GlaxoSmithKline Australia Pty Ltd
-
Cancellation by sponsorRequested by GlaxoSmithKline Australia Pty Ltd